NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
23/09/2025
Voltar para busca
Dado oficial do USPTO
PHARMAVENTURES
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Snapshot rápido
PHARMAVENTURES
ST13
US500000086455967Classe
35, 36, 42, 45
Pedido
86455967
Registro
4772557
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
26
Atualização mais recente
14/10/2025
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
35, 36, 42, 45
Data de depósito
17/11/2014
Data de registro
14/07/2015
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
23/09/2025
Última transação
14/10/2025
Escritório responsável
United States Patent and Trademark Office
Código da situação
800
Cadastro oficial
Principal Register
Primeiro uso
30/11/1997
Primeiro uso no comércio
30/11/1997
Código do desenho
4
Tipo de titular
16
Localização do titular
Oxford, GB
Examinador
BRODY,DANIEL S
Localização atual
PUBLICATION AND ISSUE SECTION
Titulares e representantes
Titulares
Pharmaventures Limited
Representantes
Laurence P. Colton SMITH TEMPEL BLAHA LLC
Classificação técnica
Classes Nice
Classe 35Classe 36Classe 42Classe 45
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 35
Advertisingmarketing and promotion services in the field of conceptsproductssupplements and preparations related to medicationdietetic products medicated and non-medicated additives for foodstuffs and beveragesdiagnostic products; Business acquisition and merger consultation; Business advisory services in the field of pharmaceuticalhealthcare researchmedicated and non-medicated food and beverage and dietary supplements industriesproduct licensing and transfer services for other of pharmaceutical drugsmedical devicesdrug delivery devicesdiagnostics and platform technologies that accelerate drug discovery and development; Business consulting and management in the field of clinical trialsclinical data and regulatory submission management on behalf of medicalbiopharmaceutical and biotechnology companies to assist them with clinical researchclinical trials and applications for drug approval; Business consulting services in the field of pharmaceuticalhealthcare researchmedicated and non-medicated food and beverage and dietary supplements industriesproduct licensing and transfer services for other of pharmaceutical drugsmedical devicesdrug delivery devicesdiagnostics and platform technologies that accelerate drug discovery and development; Business research services in the field of healthcare research and development of pharmaceuticals and dietary preparationssubstancessupplements performed for others; business consulting services in the field of assisting others in obtaining clinical trial and research services in the fields of pharmaceuticals and biotechnology; Business strategy development services; Consulting services in the field of managing intellectual properties; Consulting services in the field of medical product approval for commercial purposes; Expert evaluations and reports relating to business matters; Market research services
Classe 36
Intellectual property valuation services
Classe 42
Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Research and development in the pharmaceutical and biotechnology fields
Classe 45
Consulting in the field of intellectual property licensing
Publicações
Histórico de despachos e eventos da marca no USPTO.
26 publicações encontradas
RNL1
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
23/09/2025
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
23/09/2025
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
22/09/2025
E89R
TEAS SECTION 8 & 9 RECEIVED
30/05/2025
REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
14/07/2024
NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
01/10/2021
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
01/10/2021
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
01/10/2021
E815
TEAS SECTION 8 & 15 RECEIVED
18/06/2021
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
14/07/2020
R.PR
REGISTERED-PRINCIPAL REGISTER
14/07/2015
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
28/04/2015
PUBO
PUBLISHED FOR OPPOSITION
28/04/2015
DOCK
ASSIGNED TO EXAMINER
20/04/2015
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
08/04/2015
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
21/03/2015
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
21/03/2015
XAEC
EXAMINER'S AMENDMENT ENTERED
17/03/2015
ALIE
ASSIGNED TO LIE
17/03/2015
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
17/03/2015
GNEA
EXAMINERS AMENDMENT E-MAILED
17/03/2015
CNEA
EXAMINERS AMENDMENT -WRITTEN
17/03/2015
DOCK
ASSIGNED TO EXAMINER
07/03/2015
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
22/11/2014
NWAP
NEW APPLICATION ENTERED
20/11/2014
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace PHARMAVENTURES ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.